AVO Stock Overview
Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Advanced Oncotherapy plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.018 |
| 52 Week High | UK£0.18 |
| 52 Week Low | UK£0.018 |
| Beta | 0.061 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -89.71% |
| 3 Year Change | -94.26% |
| 5 Year Change | -95.51% |
| Change since IPO | -99.79% |
Recent News & Updates
Shareholder Returns
| AVO | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | -1.4% | -1.4% |
| 1Y | -89.7% | -7.8% | -2.4% |
Return vs Industry: AVO underperformed the UK Medical Equipment industry which returned -7.4% over the past year.
Return vs Market: AVO underperformed the UK Market which returned -2.4% over the past year.
Price Volatility
| AVO volatility | |
|---|---|
| AVO Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: AVO has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AVO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 174 | Nicolas Serandour | www.avoplc.com |
Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
Advanced Oncotherapy plc Fundamentals Summary
| AVO fundamental statistics | |
|---|---|
| Market cap | UK£9.50m |
| Earnings (TTM) | -UK£32.60m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.3x
P/E RatioIs AVO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AVO income statement (TTM) | |
|---|---|
| Revenue | UK£0 |
| Cost of Revenue | UK£0 |
| Gross Profit | UK£0 |
| Other Expenses | UK£32.60m |
| Earnings | -UK£32.60m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.06 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 39.6% |
How did AVO perform over the long term?
See historical performance and comparison